Pluvicto Plus Xtandi Enhances Anti-Tumor Activity for Some Patients With Prostate Cancer
Data presented at ESMO “provides strong evidence for an enhanced anti-cancer effect with the combination” of Pluvicto and Xtandi, according to one expert.
Side Effects Manageable From Talzenna/Xtandi Treatment in Prostate Cancer Subset
Side effects such as anemia and other blood-related events were resolved with dose reductions and/or supportive care in men with metastatic castration-resistant prostate cancer.